Can Just-in-Time Clinical Trials Reduce Disparities in Participation?
August 16th 2022Just-in-time trials are 1 tool capable of rapidly increasing access to clinical trials to develop drugs that treat the diverse and unique tapestry of patients across the United States, especially patients with more diverse racial, ethnic, and socioeconomic backgrounds.
Differentiating Pseudoprogression From Hyperprogression in Patients Treated With Immunotherapies
February 14th 2022Advances in the field have also led to the recognition of other clinical challenges, including unforeseen observations and complications associated with choosing the sequencing of appropriate therapeutic interventions as well as the management of drug-related complications.
The Role of In-Office Next Generation Sequencing to Advance Precision Medicine in Community Oncology
May 13th 2021The goal of precision medicine is to advance medical and scientific discoveries to offer more tailored, precise, and accurate health interventions to maximize the health benefits for patients.
Despite Advances in Precision Medicine, Disparities Persist
November 23rd 2020The goal of precision medicine is to advance medical and scientific discoveries while offering more tailored, precise, and accurate health interventions, thus maximizing health benefits for patients while reducing adverse effects and overall cost of care.
Next-Generation Sequencing Can Improve Treatment Decisions, But Community Uptake Remains Delayed
November 18th 2019Precision medicine has afforded oncologists the opportunity to develop individualized approaches to treat non–small cell lung cancer, one of the most devastating malignant disorders, which until the past decade was thought to be invariably fatal within months.